Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali

Background. The monovalent meningococcal A conjugate vaccine (PsA-TT, MenAfriVac) was developed for use in the “meningitis belt” of sub-Saharan Africa. Mali was 1 of 3 countries selected for early introduction. As this is a new vaccine, postlicensure surveillance is particularly important to identif...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Infect Dis
Huvudupphovsmän: Vannice, Kirsten S., Keita, Modibo, Sow, Samba O., Durbin, Anna P., Omer, Saad B., Moulton, Lawrence H., Yaméogo, Téné M., Zuber, Patrick L. F., Onwuchekwa, Uma, Sacko, Massambou, Diomandé, Fabien V. K., Halsey, Neal A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2015
Ämnen:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639483/
https://ncbi.nlm.nih.gov/pubmed/26553680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ497
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk